Comparing Frailty Screenings in Older Breast Cancer Patients
Part of Cancer clinical trials.
This study compares different ways to check frailty (a measure of how well your body handles stress) in women with breast cancer who are 50 or older. The goal is to find which screening tool best predicts health outcomes during treatment.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with breast cancer.
- You are 50 years old or older.
- Your care team plans to treat you with both surgery and chemotherapy.
- You can walk on your own (with or without a cane or walker).
- You do not have any other type of cancer, a terminal illness, or a condition that makes it hard to communicate or cooperate.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests how well simple frailty screening tools predict recovery and complications after major surgery in people aged 70 and older. The goal is to help doctors and patients better understand surgical risks.
This study tests a simple frailty screening tool in older adults before major surgery. It aims to see if the tool helps identify patients who might need extra support before and after their operation.
This study looks at how frailty (weakness and tiredness) affects the daily life and well-being of women 60 or older who have just been diagnosed with a common type of breast cancer. The goal is to understand their needs better so doctors can provide more supportive care.
This trial studies simple “frailty” assessments (tests of strength, memory, and daily functioning) to better predict risk in people with gynecologic cancers who are planning or having surgery. If you qualify, the results may help doctors identify who needs extra support before and after surgery.
This study evaluates how to better assess and manage frailty (age-related weakness and vulnerability) in older cancer patients aged 70 and up who are starting chemotherapy or other cancer treatments. The goal is to help doctors tailor treatment plans to each patient's individual strength and health status.
This study looks at “frailty,” or how well the body may handle stress, around the time of surgery in people age 65 and older. It may help doctors better understand who is at higher risk and how to plan care around surgery.
Hear when a new Frailty Syndrome trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.